*EMBARGOED All research presented at the 2023 ACG Annual Scientific Meeting and Postgraduate Course is strictly embargoed until Sunday, October 22, 2023, at 3:00 pm PT.
Oral 30 – The Effect of Low-Dose Aspirin on Disease Activity in Pregnant Individuals with Inflammatory Bowel Disease
Tuesday, October 24, 2023 | 8:50 AM – 9:00 AM PT | Location: Ballroom B
Author Insight from Amy Yu, MD, University of California, San Francisco
What’s new here and important for clinicians?
Approximately one-third of patients with IBD cared for in a maternal fetal medicine practice used low-dose aspirin for prevention of hypertensive disorders of pregnancy. The observed rate of IBD flare during pregnancy or postpartum was not higher in patients who used low-dose aspirin.
What do patients need to know?
The use of low-dose aspirin among pregnant women with IBD for prevention of hypertensive disorders of pregnancy was not associated with an increased risk of disease activity.
Read the Abstract
Amy Yu, MD, University of California, San Francisco
amy.yu [at] ucsf.edu
Media Interview Requests
To arrange an interview with any ACG experts or abstract authors, please contact Becky Abel of ACG via email at mediaonly [at] gi.org or by phone at 301-263-9000.